Diane Havlir, MD
|School||UCSF School of Medicine|
|Address||SFGH Bldg 80|
The goal of my research is to develop therapeutic strategies that reduce the HIV burden on an individual and population level. Antiretroviral therapy has been one of the greatest successes in medicine, yet we are unable determine how to use it to eradicate HIV or deploy it to turn the HIV epidemic around globally. Further, antiretroviral therapy can reduce the global TB and malaria burden, but the optimal strategies have not been determined. Current areas of focus of our group include translational and intervention studies targeting the gut as a major residual reservoir for HIV in antiretroviral treated patients. Internationally, through the Makerere University - UCSF (MU-UCSF) research collaboration and the ACTG we are studying 1) optimal treatment strategies for HIV and TB, including new TB agents 2) strategies to reduce HIV and malaria burden in children and pregnant women. We are also developing approaches to treat HIV earlier in the course of disease in a sustainable manner that benefits the overall health, education and economics of communities in East Africa.
Click the "See All" links for more information and interactive visualizations!
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share similar concepts with this person.